# Alife Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/alife-health

- Industry: Software
- Headquarters: San Francisco, US
- Website: www.alifehealth.com
- Total disclosed funding: $32M
- Latest round: Series A (Mar 22, 2022)
- Investors on record: 6

## About

Founded in 2020 and based in California, US, Alife Health, Inc. is a fertility technology company that develops and provides AI (artificial intelligence)-based tools for fertility specialists. Founder and CEO Mr. Paxton Maeder-York used to develop surgical robots for lung cancer, is currently focused on integrating artificial intelligence and machine learning into in vitro fertilization (IVF) treatments. In May 2021, Lux Capital led a USD 9.5 million Seed financing for Alife Health, Inc. 

The company's development team offers an AI-based operating system that enables fertility specialists to improve the reproductive outcomes of patients suffering from infertility. The platform provides data used to create a personalized treatment for in vitro fertilization (IVF) patients.

Alife Health, Inc. will use the May 2021 funding to double its 11 full-time employees by the end of 2021 for scaling up the company's software through regulatory submissions and out to patients.

## Funding rounds

- Series A, Mar 22, 2022, $22M — Maveron, Union Square Ventures, Lux Capital
- Seed, May 3, 2021, $9.5M — Lux Capital, IA Ventures, Amplo, Springbank Collective

## Investors

- Lux Capital (https://capitalatlas.ai/funds/lux-capital) — Seed, Series A
- IA Ventures (https://capitalatlas.ai/funds/ia-ventures) — Seed
- Amplo (https://capitalatlas.ai/funds/amplo) — Seed
- Springbank Collective (https://capitalatlas.ai/funds/springbank-collective) — Seed
- Maveron (https://capitalatlas.ai/funds/maveron) — Series A
- Union Square Ventures (https://capitalatlas.ai/funds/union-square-ventures) — Series A